Cargando…
Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy
BACKGROUND: The discovery of the fusion gene echinodermmicro tubule associated proteinlike 4-anaplastic lymphoma kinase, EML4-ALK, in patients with non-small-cell lung cancer has led to the remarkable development of anaplastic lymphoma kinase inhibitors, such as crizotinib. Consequently, the clinica...
Autores principales: | Wang, Qiushi, He, Yong, Yang, Xin, Wang, Yubo, Xiao, Hualiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027997/ https://www.ncbi.nlm.nih.gov/pubmed/24885608 http://dx.doi.org/10.1186/1471-2466-14-83 |
Ejemplares similares
-
Metformin restores crizotinib sensitivity in crizotinib-resistant human lung cancer cells through inhibition of IGF1-R signaling pathway
por: Li, Li, et al.
Publicado: (2016) -
Extraordinary response of metastatic pancreatic cancer to apatinib after failed chemotherapy: A case report and literature review
por: Li, Cheng-Ming, et al.
Publicado: (2017) -
Complete response with crizotinib in two children with chemotherapy resistant neuroblastoma
por: Verma, Priyanka, et al.
Publicado: (2017) -
Hexokinases II‐mediated glycolysis governs susceptibility to crizotinib in ALK‐positive non‐small cell lung cancer
por: Lin, Caiyu, et al.
Publicado: (2021) -
Peripheral Lung Squamous Carcinoma With ROS1 Rearrangement Sensitive to Crizotinib: A Case Report
por: Yang, Guangdie, et al.
Publicado: (2021)